Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024
Compare Profit and Loss Results of Bajaj Healthcare
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
542.00
268.00
274.00
102.24%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
542.00
268.00
274.00
102.24%
Expenditure (Ex Depriciation)
Stock Adjustments
-20.00
-2.00
-18.00
-900.00%
Raw Materials Consumed
307.00
98.00
209.00
213.27%
Power & Fuel Cost
22.00
0.00
22.00
0%
Employee Cost
57.00
70.00
-13.00
-18.57%
Operating Expenses
63.00
0.00
63.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
6.00
24.00
-18.00
-75.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
6.00
0.00
6.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
460.00
217.00
243.00
111.98%
Operating Profit (PBDIT) excl Other Income
82.00
51.00
31.00
60.78%
Other Income
19.00
8.00
11.00
137.50%
Operating Profit (PBDIT)
101.00
59.00
42.00
71.19%
Interest
27.00
0.00
27.00
0%
Profit before Depriciation and Tax
73.00
58.00
15.00
25.86%
Depreciation
27.00
8.00
19.00
237.50%
Profit Before Taxation & Exceptional Items
46.00
50.00
-4.00
-8.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
46.00
69.00
-23.00
-33.33%
Provision for Tax
3.00
14.00
-11.00
-78.57%
Profit After Tax
42.00
55.00
-13.00
-23.64%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
267.00
104.00
163.00
156.73%
Profit Available for appropriations
310.00
159.00
151.00
94.97%
Appropriations
310.00
159.00
151.00
94.97%
Equity Dividend (%)
20%
125%
-105.00
Earnings Per Share
13.29
8.26
5.03
60.90%
Profit And Loss - Net Sales
Net Sales 542.60 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.61% vs -26.69% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 82.43 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 8.08% vs -31.52% in Mar 2024
Profit And Loss - Interest
Interest 27.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -5.98% vs 69.01% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 42.93 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 399.64% vs -122.55% in Mar 2024






